Gmo Us is trading at 12.55 as of the 21st of March 2025; that is 0.48 percent decrease since the beginning of the trading day. The fund's open price was 12.61. Gmo Us has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Under normal circumstances, the fund invests directly and indirectly at least 80 percent of its assets in equities tied economically to the United States. GMO US is traded on NASDAQ Exchange in the United States. More on Gmo Equity Allocation
Gmo Equity Allocation [GMCQX] is traded in USA and was established 21st of March 2025. Gmo Us is listed under GMO category by Fama And French industry classification. The fund is listed under Large Value category and is part of GMO family. This fund currently has accumulated 988.89 M in assets under management (AUM) with minimum initial investment of 300 M. Gmo Equity Allocation is currently producing year-to-date (YTD) return of 0.91% with the current yeild of 0.0%, while the total return for the last 3 years was 11.03%.
Check Gmo Us Probability Of Bankruptcy
Instrument Allocation
Top Gmo Equity Allocation Mutual Fund Constituents
Gmo Us financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Us security.